Siphat

SIPHAT (Société des Industries Pharmaceutiques de Tunisie) is the leading state-controlled pharmaceutical company in Tunisia, specializing in the industrial production of essential medicines. The company manufactures a diverse portfolio of generic drugs across multiple therapeutic areas, including cardiovascular health, metabolic disorders, and infectious diseases. SIPHAT operates advanced manufacturing facilities that produce various dosage forms such as tablets, syrups, and injectables, including insulin. In addition to its own product line, the company serves as a strategic partner for international pharmaceutical firms, providing contract manufacturing and local distribution services. Listed on the Tunis Stock Exchange, SIPHAT plays a critical role in the Tunisian national healthcare system by ensuring the availability of affordable, high-quality medications.